AI Verdict
SBFMW has stronger fundamentals based on our AI analysis.
SBRA vs SBFMW Fundamental Comparison
| Metric | SBRA | SBFMW |
|---|---|---|
| Revenue | $774.6M | $36.3M |
| Net Income | $155.6M | $-6.0M |
| Net Margin | 20.1% | -16.5% |
| ROE | 5.5% | -25.9% |
| ROA | 2.8% | -19.9% |
| Current Ratio | N/A | 4.17x |
| Debt/Equity | 0.90x | 0.09x |
| EPS | $0.64 | $-0.98 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
SBRA vs SBFMW: Frequently Asked Questions
Is SBRA or SBFMW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), SBFMW has stronger fundamentals. SBRA is rated SELL (70% confidence) while SBFMW is rated SELL (78% confidence). This is not investment advice.
How does SBRA compare to SBFMW fundamentally?
Sabra Health Care REIT, Inc. has ROE of 5.5% vs Sunshine Biopharma Inc.'s -25.9%. Net margins are 20.1% vs -16.5% respectively.
Which stock pays higher dividends, SBRA or SBFMW?
SBRA has a dividend yield of N/A or no dividend while SBFMW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in SBRA or SBFMW for long term?
For long-term investing, consider that SBRA has SELL rating with 70% confidence, while SBFMW has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about SBRA vs SBFMW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For SBRA vs SBFMW, the AI consensus favors SBFMW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.